Koos OWES the stockholders(owners) an explanation as to the direction and technology applications. WILL the stemcell therapy be applied to canines and felines? The shareholders should not have to speculate on this and should be told by the CEO. Christine Ichim was initially hired for ENTB but has been redirected..Does that redirection apply to PETS. This gets old.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.